Zaloguj się

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

The Process

Genes can be randomly knocked out, or specific genes can be targeted. To knock out a particular gene, an engineered piece of DNA called a targeting vector is used to replace the normal gene, thereby inactivating it.

Targeting vectors have sequences on each end that are identical—or homologous— to the sequences flanking each side of the gene of interest. These homologous sequences allow the targeting vector to replace the gene through homologous recombination—a process that occurs naturally between DNA with similar sequences during meiosis.

The targeting vector is introduced into mouse embryonic stem cells in culture, using methods such as electroporation—use of electric pulses to temporarily create pores in the cell membrane. Typically, to identify cells where the vector has properly replaced the gene, it is designed to include a positive selection marker—such as the gene for neomycin resistance (NeoR)—between the homologous regions; and a negative selection marker—such as the gene for viral thymidine kinase (TK)—after one of the homologous regions.

The cells are exposed to neomycin, and only those that have incorporated the vector into their DNA will survive because they have the NeoR gene. Also, cells, where the vector has replaced the targeted gene through homologous recombination, will not have the TK gene, allowing them to survive in the presence of the drug ganciclovir. Therefore, exposure to ganciclovir is used to eliminate cells that have the vector randomly inserted into their genome, because these cells will have the TK gene.

The cells with the gene properly knocked out are then inserted into a mouse embryo, which is implanted into the uterus of a female, where it develops until birth. The resulting mouse is a chimera—meaning it is composed of a mixture of cells—some with normal DNA from the embryo, and some with the gene knocked out on one chromosome from the engineered cells. These mice are bred, and offspring containing the gene in their germline are further crossbred to create a line of mice where every cell is homozygous for the knockout. These knockout mice can then be used to study gene function.

Tagi
In vitro MutagenesisKnock Out GeneTargeting VectorNeomycin ResistanceThymidine KinaseEmbryonic Stem CellsHomologous RecombinationPositive Selection MarkerNegative Selection MarkerKnockout MiceGenetically Engineered AnimalsHuman Diseases

Z rozdziału 15:

article

Now Playing

15.8 : In-vitro Mutagenesis

Biotechnology

13.5K Wyświetleń

article

15.1 : Co to jest inżynieria genetyczna?

Biotechnology

72.3K Wyświetleń

article

15.2 : Wybór antybiotyków

Biotechnology

51.5K Wyświetleń

article

15.3 : Rekombinowane DNA

Biotechnology

92.3K Wyświetleń

article

15.4 : Organizmy transgeniczne

Biotechnology

30.4K Wyświetleń

article

15.5 : Dorosłe komórki macierzyste

Biotechnology

27.7K Wyświetleń

article

15.6 : Embrionalne komórki macierzyste

Biotechnology

26.0K Wyświetleń

article

15.7 : Indukowane pluripotencjalne komórki macierzyste

Biotechnology

21.5K Wyświetleń

article

15.9 : Izolacja DNA

Biotechnology

189.8K Wyświetleń

article

15.10 : Terapia genowa

Biotechnology

24.7K Wyświetleń

article

15.11 : Klonowanie reprodukcyjne

Biotechnology

29.4K Wyświetleń

article

15.12 : Technologia CRISPR (CRISPR)

Biotechnology

47.9K Wyświetleń

article

15.13 : Komplementarne DNA

Biotechnology

28.7K Wyświetleń

article

15.14 : Metoda PCR

Biotechnology

203.1K Wyświetleń

article

15.15 : Genomika

Biotechnology

35.0K Wyświetleń

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone